Client Successes

Advising a Leading Proteomics and Drug Discovery Company

We represented a proteomics and drug discovery company in connection with a research, development and commercialization collaboration with a company possessing human antibody technology, including the development and commercialization of human antibodies directed against more than 100 different protein targets. Our service to this client has included devising a number of business and legal mechanisms for prioritizing the different protein targets, maintaining commercialization rights in certain fields, and protecting against claims of intellectual property infringement.

Commercializing Next Generation Product for a Leading Data Storage Equipment Maker

Our lawyers provided counsel to a publicly traded maker of data storage equipment in developing and commercializing its next generation storage product, including the drafting and negotiating of letters of intent and development agreements with six manufacturers of data storage medium, five of which are Japanese. Subsequent agreements involved equipment sale agreements and tooling agreements with all six companies. In addition, we assisted our client in designing and implementing a basic order and procurement agreement for the company, allowing it to obtain parts to manufacture data storage equipment on a just-in-time basis from several OEMs.

Driving Scientific Innovation through Sponsored-research Agreements

Our lawyers have prepared numerous sponsored-research agreements between biotechnology and other companies, universities and not-for-profit institutions. In these arrangements, we work with our clients and the licensing university to arrange for a suitable disposition of the ownership of new inventions and commercialization rights. In addition, our lawyers have negotiated several such agreements with foreign universities and research institutions.

Helping a Canadian Proteomics and Drug Discovery Company

Our lawyers helped a Canadian proteomics and drug discovery company in the establishment of its first proteomics research facility in the United States, a facility closely tied to a prominent U.S. academic research institution. This new facility enables the company to further develop and market its proteomics methodologies both in the United States and internationally.

Helping to Bring Technology and Sciences Together

Our lawyers represent a software company specializing in data visualization and query tools for use in applications ranging from drug discovery to biotechnology, including agreements covering domestic and international software distribution and bundling, enterprise licenses, shareware licenses, joint marketing and partnering.

Protecting a Global Genetics Testing Company

Our lawyers served as counsel for a genetics testing company in connection with domestic and international licensing of patented technologies to detect human susceptibility to genetically influenced disease. Our work with this client included advising on the revamping of its U.S. marketing and supply relationships, as well as the termination of a previous European distribution contract and the preparation of a broader license agreement with a potential new European partner. Our lawyers also worked actively with the client to develop a licensing strategy that takes into account its business goals and intellectual property position.
First Previous 1 Next Last